FP13.02 Pembrolizumab + Pemetrexed-Platinum vs Pemetrexed-Platinum for Metastatic NSCLC: 4-Year Follow-up From KEYNOTE-189
2021
-
Correction
-
Source
-
Cite
-
Save
0
References
7
Citations
NaN
KQI